Literature DB >> 27595710

The MEssaging for Diabetes Intervention Reduced Barriers to Medication Adherence Among Low-Income, Diverse Adults With Type 2.

Lindsay S Mayberry1,2,3, Shelagh A Mulvaney3,4, Kevin B Johnson5,6, Chandra Y Osborn1,2,3,5.   

Abstract

BACKGROUND: Nonadherence to diabetes medication is prevalent and costly. MEssaging for Diabetes (MED), a mobile health (mHealth) intervention, identified and addressed user-specific barriers to medication adherence. We assessed whether MED reduced users' targeted barriers and if barrier reductions were associated with within-participant improvements in adherence or glycemic control (HbA1c).
METHODS: Adults (N = 80) with type 2 diabetes completed self-report measures identifying barriers to adherence at baseline and monthly for 3 months. At each assessment, 17 barriers were assessed and ranked for each user. Each subsequent month, users received daily text messages addressing their 3 highest ranked barriers. Targeted barriers were different for each participant and could change monthly. Paired t-tests assessed within-participant improvement in targeted barriers each month, and nested regression models assessed if changes in a participant's barrier scores were associated with improvements in adherence and HbA1c.
RESULTS: Participants were 69% non-white and 82% had incomes <$25K. Average HbA1c was 8.2 ± 2.0%. Assessment completion rates were 100% at baseline, 59% at 1 month, 30% at 2 months, and 65% at 3 months. The most commonly reported barriers were the cost of medications (76%), believing medications are harmful (58%), and lacking information about medications (53%). Participants' barrier scores improved each month and barrier improvement predicted adherence assessed via nightly adherence assessment text messages ( P < .001). Among participants who completed assessments each month, barrier improvement in months 2 and 3 ( P < .05) predicted HbA1c improvement.
CONCLUSIONS: Iterative, individual tailoring may overcome users' barriers to adherence. Attrition is a challenge for mHealth interventions among low-income patients.

Entities:  

Keywords:  intervention; mHealth; medication adherence; mobile phone; text message; type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27595710      PMCID: PMC5375078          DOI: 10.1177/1932296816668374

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  34 in total

1.  Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients.

Authors:  Gbenga Ogedegbe; Carol A Mancuso; John P Allegrante; Mary E Charlson
Journal:  J Clin Epidemiol       Date:  2003-06       Impact factor: 6.437

2.  Minimal intervention needed for change: definition, use, and value for improving health and health research.

Authors:  Russell E Glasgow; Lawrence Fisher; Lisa A Strycker; Danielle Hessler; Deborah J Toobert; Diane K King; Tom Jacobs
Journal:  Transl Behav Med       Date:  2014-03       Impact factor: 3.046

Review 3.  Behavior change interventions delivered by mobile telephone short-message service.

Authors:  Brianna S Fjeldsoe; Alison L Marshall; Yvette D Miller
Journal:  Am J Prev Med       Date:  2009-02       Impact factor: 5.043

Review 4.  Medication adherence and persistence: a comprehensive review.

Authors:  Kem P Krueger; Bruce A Berger; Bill Felkey
Journal:  Adv Ther       Date:  2005 Jul-Aug       Impact factor: 3.845

5.  Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse.

Authors:  John D Piette; Michele Heisler; Anita Harand; Michelina Juip
Journal:  J Health Care Poor Underserved       Date:  2010-02

6.  Stressors may compromise medication adherence among adults with diabetes and low socioeconomic status.

Authors:  Chandra Y Osborn; Lindsay Satterwhite Mayberry; Julie A Wagner; Garry W Welch
Journal:  West J Nurs Res       Date:  2014-02-25       Impact factor: 1.967

Review 7.  Health behavior models in the age of mobile interventions: are our theories up to the task?

Authors:  William T Riley; Daniel E Rivera; Audie A Atienza; Wendy Nilsen; Susannah M Allison; Robin Mermelstein
Journal:  Transl Behav Med       Date:  2011-03       Impact factor: 3.046

8.  Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes.

Authors:  Lyndsay A Nelson; Shelagh A Mulvaney; Tebeb Gebretsadik; Yun-Xian Ho; Kevin B Johnson; Chandra Y Osborn
Journal:  J Am Med Inform Assoc       Date:  2015-07-17       Impact factor: 4.497

Review 9.  Healthcare via cell phones: a systematic review.

Authors:  Santosh Krishna; Suzanne Austin Boren; E Andrew Balas
Journal:  Telemed J E Health       Date:  2009-04       Impact factor: 3.536

10.  Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control.

Authors:  Charlene C Quinn; Michelle D Shardell; Michael L Terrin; Erik A Barr; Shoshana H Ballew; Ann L Gruber-Baldini
Journal:  Diabetes Care       Date:  2011-07-25       Impact factor: 19.112

View more
  12 in total

1.  Nonmedical Interventions For Type 2 Diabetes: Evidence, Actionable Strategies, And Policy Opportunities.

Authors:  Leonard E Egede; Rebekah J Walker; Sebastian Linde; Jennifer A Campbell; Aprill Z Dawson; Joni S Williams; Mukoso N Ozieh
Journal:  Health Aff (Millwood)       Date:  2022-06-27       Impact factor: 9.048

2.  Making Inroads in Addressing Population Health in Underserved Communities With Type 2 Diabetes.

Authors:  Luigi F Meneghini; Addie L Fortmann; Taylor L Clark; Kellie Rodriguez
Journal:  Diabetes Spectr       Date:  2019-11

3.  Disparities in Text Messaging Interventions to Improve Diabetes Management in the United States.

Authors:  Amy A Eyler; Francine C Gachupin; Shelly L Johnston; Julie M Kapp; Diana C Parra; Mihail Popescu
Journal:  Diabetes Spectr       Date:  2021-01

4.  Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach.

Authors:  Nicole M Alberts; Sherif M Badawy; Jerlym S Porter; Jane S Hankins; Jason Hodges; Jeremie H Estepp; Chinonyelum Nwosu; Hamda Khan; Matthew P Smeltzer; Ramin Homayouni; Sarah Norell; Lisa Klesges
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-08       Impact factor: 4.773

Review 5.  A perspective on nonadherence to drug therapy: psychological barriers and strategies to overcome nonadherence.

Authors:  Leslie R Martin; Cheyenne Feig; Chloe R Maksoudian; Kenrick Wysong; Kate Faasse
Journal:  Patient Prefer Adherence       Date:  2018-08-22       Impact factor: 2.711

6.  An Analysis of Whether Health Literacy and Numeracy Are Associated with Diabetes Medication Adherence.

Authors:  Arathi S Nandyala; Lyndsay A Nelson; Andrea E Lagotte; Chandra Y Osborn
Journal:  Health Lit Res Pract       Date:  2018-01-23

7.  Usability, Usefulness, and Acceptance of a Novel, Portable Rehabilitation System (mRehab) Using Smartphone and 3D Printing Technology: Mixed Methods Study.

Authors:  Sutanuka Bhattacharjya; Lora Anne Cavuoto; Brandon Reilly; Wenyao Xu; Heamchand Subryan; Jeanne Langan
Journal:  JMIR Hum Factors       Date:  2021-03-22

8.  Mobile Phone Support for Diabetes Self-Care Among Diverse Adults: Protocol for a Three-Arm Randomized Controlled Trial.

Authors:  Lyndsay A Nelson; Kenneth A Wallston; Sunil Kripalani; Robert A Greevy; Tom A Elasy; Erin M Bergner; Chad K Gentry; Lindsay S Mayberry
Journal:  JMIR Res Protoc       Date:  2018-04-10

9.  Incorporating Behavioral Trigger Messages Into a Mobile Health App for Chronic Disease Management: Randomized Clinical Feasibility Trial in Diabetes.

Authors:  Scott Sittig; Jing Wang; Sriram Iyengar; Sahiti Myneni; Amy Franklin
Journal:  JMIR Mhealth Uhealth       Date:  2020-03-16       Impact factor: 4.773

10.  Development and Evaluation of a Tailored Mobile Health Intervention to Improve Medication Adherence in Black Patients With Uncontrolled Hypertension and Type 2 Diabetes: Pilot Randomized Feasibility Trial.

Authors:  Antoinette Schoenthaler; Michelle Leon; Mark Butler; Karsten Steinhaeuser; William Wardzinski
Journal:  JMIR Mhealth Uhealth       Date:  2020-09-23       Impact factor: 4.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.